MA45367B1 - Tyrosine kinase inhibitors - Google Patents

Tyrosine kinase inhibitors

Info

Publication number
MA45367B1
MA45367B1 MA45367A MA45367A MA45367B1 MA 45367 B1 MA45367 B1 MA 45367B1 MA 45367 A MA45367 A MA 45367A MA 45367 A MA45367 A MA 45367A MA 45367 B1 MA45367 B1 MA 45367B1
Authority
MA
Morocco
Prior art keywords
tyrosine kinase
kinase inhibitors
compounds
btk
inhibitors
Prior art date
Application number
MA45367A
Other languages
French (fr)
Inventor
David Goldstein
Timothy D Owens
Original Assignee
Principia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Principia Biopharma Inc filed Critical Principia Biopharma Inc
Priority claimed from PCT/US2016/035588 external-priority patent/WO2016196840A1/en
Publication of MA45367B1 publication Critical patent/MA45367B1/en

Links

Abstract

La présente invention concerne des composés qui sont des inhibiteurs de la tyrosine kinase, en particulier des inhibiteurs de la tyrosine kinase de bruton ("btk"), et sont par conséquent utiles pour le traitement de maladies pouvant être traitées par l'inhibition de la btk telle que le cancer, les maladies auto-immunes, inflammatoires, et thromboemboliques. L'invention concerne également des compositions pharmaceutiques contenant de tels composés et des procédés de préparation de tels composés.The present invention relates to compounds which are inhibitors of tyrosine kinase, in particular inhibitors of bruton tyrosine kinase ("btk"), and therefore are useful for the treatment of diseases treatable by inhibition of the. btk such as cancer, autoimmune, inflammatory, and thromboembolic diseases. The invention also relates to pharmaceutical compositions containing such compounds and to methods of preparing such compounds.

MA45367A 2015-06-03 2016-06-02 Tyrosine kinase inhibitors MA45367B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562170547P 2015-06-03 2015-06-03
PCT/US2016/035588 WO2016196840A1 (en) 2015-06-03 2016-06-02 Tyrosine kinase inhibitors

Publications (1)

Publication Number Publication Date
MA45367B1 true MA45367B1 (en) 2021-09-30

Family

ID=59724528

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45367A MA45367B1 (en) 2015-06-03 2016-06-02 Tyrosine kinase inhibitors

Country Status (3)

Country Link
AR (1) AR104865A1 (en)
EC (1) ECSP18000097A (en)
MA (1) MA45367B1 (en)

Also Published As

Publication number Publication date
AR104865A1 (en) 2017-08-23
ECSP18000097A (en) 2018-10-31

Similar Documents

Publication Publication Date Title
MA49809A1 (en) Compounds used as kinase inhibitors
PH12017502203A1 (en) Tyrosine kinase inhibitors
MA39219B1 (en) New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis
MA40111A1 (en) Derivatives of tetrahydronaphthalene inhibiting mcl-1 protein
EA202091709A1 (en) DNA PC INHIBITORS
MX2022004513A (en) Bicyclic heterocycles as fgfr inhibitors.
TN2014000420A1 (en) INDOLE AND INDAZOLE DERIVATIVES THAT ACTIVATE MPK
MA40768A (en) MONO OR DI-SUBSTITUTE INDOLE DERIVATIVES AS DENGUE VIRUS REPLICATION INHIBITORS
MA38284A1 (en) Inhibitors of 2,3-dihydroimidazol [1,2-c] pyrimidin-5 (1 h) -one-2-lipoprotein-associated phospholipase (lp-pla2)
MA41238A (en) DERIVATIVES 5 - [(PIPERAZIN-1-YL) -3-OXO-PROPYL] -IMIDAZOLIDINE-2,4-DIONE AS ADAMT INHIBITORS FOR THE TREATMENT OF OSTEOARTHRIT
EA202091708A1 (en) DNA PC INHIBITORS
MA40875A (en) 2,4-DIAMINO-QUINOLEIN SUBSTITUTED AS NEW ANTI-CANCER AGENTS
MA42776B1 (en) Compounds useful for inhibiting t-ror
PH12021550743A1 (en) Boron containing pde4 inhibitors
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
MA38678A1 (en) Nucleoside derivatives 4'-azido, 3'-deoxy-3'-fluoro substituted
MA39253B1 (en) Substituted bicyclic heteroaryl compounds used as rxr agonists
MX2022008627A (en) Substituted pyrazolo-pyrimidines and uses thereof.
MA45367B1 (en) Tyrosine kinase inhibitors
MA35860B1 (en) Quinoline derivatives as pde10a enzyme inhibitors
MA43507B1 (en) Mono or di-substituted indole derivatives as dengue virus replication inhibitors
MA49994A1 (en) Macrocyclic compounds for the treatment of disease
MA54770A1 (en) Compounds used as kinase inhibitors
MA42175B1 (en) Pyrazolopyrimidine derivatives as btk inhibitors for cancer treatment
MA51297B1 (en) Quinazolinones as parp14 inhibitors